NovoCure
NVCR
NVCR
303 hedge funds and large institutions have $6.2B invested in NovoCure in 2022 Q4 according to their latest regulatory filings, with 49 funds opening new positions, 96 increasing their positions, 90 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1% more funds holding
Funds holding: 301 → 303 (+2)
2% less capital invested
Capital invested by funds: $6.33B → $6.2B (-$131M)
30% less call options, than puts
Call options by funds: $137M | Put options by funds: $196M
Holders
303
Holding in Top 10
3
Calls
$137M
Puts
$196M
Top Buyers
| 1 | +$96M | |
| 2 | +$22.3M | |
| 3 | +$21.8M | |
| 4 |
BlackRock
New York
|
+$16.6M |
| 5 |
Aviva
London,
United Kingdom
|
+$8.87M |
Top Sellers
| 1 | -$98.3M | |
| 2 | -$32.4M | |
| 3 | -$28.4M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$14.9M |
| 5 |
Mitsubishi UFJ Trust & Banking
Tokyo,
Japan
|
-$11.9M |